Our 3 Treatment Target (3TT) pilot has been shortlisted for a HSJ Patient Safety Award 2019 in the category of Clinical Governance and Risk Management. The scheme was led by One Health Lewisham, commissioned by NHS Lewisham CCG to improve the diabetes care pathway for patients in Lewisham.
Diabetes is a major public health problem that affects approximately 6% of Lewisham residents. The estimated (diagnosed and undiagnosed) diabetes prevalence was 6.26% (2014/15) of people aged 16 years+, representing over 15,000 diagnosed patients and an estimated further 3,458 adults undiagnosed.
The pilot involved using targeted interventions focused on the three target treatments these were measurement for blood glucose – HbA1c £ 48mmol/mol, cholesterol < 5.0 mmol/l and blood pressure £ 140/80 delivered through practice and hub level. Through the programme we offered practices detailed analysis of current health management systems for diabetes registration, recall and review, MDTs meetings, facilitation clinics and training/peer review from the local GP federation community team. Over the last 2 years the programme has successfully reduced variation of diabetes treatment, improved overall diabetic care in Lewisham from an requires improvement to outstanding in the CCG improvement and assessment framework, helping to reduce diabetic related complications. Dr Sanjay Das, Clinical Lead for Diabetes at One Health Lewisham said: These outcomes are a result of the hard work of Lewisham practices resulting in better clinical outcomes for our residents living with diabetes. Through One Health Lewisham we have invested in clinical leadership, multi-disciplinary working and support for practices to help our patients. It’s amazing that our work has been acknowledged by HSJ Patient Safety Congress Awards as a finalist in the Clinical Governance and Risk Management category. We are in a group amongst some really inspiring and innovative work – so to be shortlisted is a fantastic achievement.